GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Artemis Investment Management LLP

Artemis Investment Management LLP raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.3% in the second quarter, HoldingsChannel reports. The firm owned 121,313 shares of the company’s stock after acquiring an additional 9,309 shares during the period. Artemis Investment Management LLP’s holdings in GE HealthCare Technologies were worth $9,453,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Prime Capital Investment Advisors LLC raised its position in shares of GE HealthCare Technologies by 42.0% during the 4th quarter. Prime Capital Investment Advisors LLC now owns 4,866 shares of the company’s stock worth $376,000 after buying an additional 1,440 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of GE HealthCare Technologies by 6.8% during the 4th quarter. International Assets Investment Management LLC now owns 7,828 shares of the company’s stock worth $605,000 after buying an additional 499 shares in the last quarter. Turtle Creek Wealth Advisors LLC bought a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $30,000. Sequoia Financial Advisors LLC raised its position in shares of GE HealthCare Technologies by 182.5% during the 4th quarter. Sequoia Financial Advisors LLC now owns 21,943 shares of the company’s stock worth $1,697,000 after buying an additional 14,175 shares in the last quarter. Finally, Cerity Partners LLC raised its position in shares of GE HealthCare Technologies by 27.2% during the 4th quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock worth $3,551,000 after buying an additional 9,809 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Activity at GE HealthCare Technologies

In related news, CEO Jan Makela sold 66,955 shares of the company’s stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the completion of the transaction, the chief executive officer now directly owns 63,348 shares in the company, valued at approximately $5,165,395.92. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Jan Makela sold 66,955 shares of the stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total value of $5,459,510.70. Following the completion of the transaction, the chief executive officer now owns 63,348 shares in the company, valued at approximately $5,165,395.92. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CTO Taha Kass-Hout sold 3,300 shares of the stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total transaction of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares of the company’s stock, valued at approximately $5,296,510. The disclosure for this sale can be found here. Insiders sold a total of 73,005 shares of company stock worth $5,941,366 in the last ninety days. 0.27% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on GEHC. The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price on the stock. Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price on the stock. Redburn Atlantic upgraded shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. Bank of America dropped their target price on shares of GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a report on Wednesday, May 1st. Finally, Mizuho cut their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. Five analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.

GE HealthCare Technologies Stock Down 1.1 %

GEHC stock traded down $0.93 during trading hours on Monday, hitting $82.47. The company’s stock had a trading volume of 336,417 shares, compared to its average volume of 3,095,320. The stock has a 50 day moving average price of $79.20 and a two-hundred day moving average price of $82.79. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.05. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.50. The company has a market capitalization of $37.64 billion, a PE ratio of 24.39, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period in the previous year, the company earned $0.92 earnings per share. GE HealthCare Technologies’s revenue for the quarter was up .5% on a year-over-year basis. On average, equities research analysts expect that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s payout ratio is currently 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.